12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Loading...
Loading...

 

Gainers

  • Gemini Therapeutics GMTX shares moved upwards by 32.92% to $3.23 during Wednesday's pre-market session. The market value of their outstanding shares is at $139.2 million.
  • Galera Therapeutics GRTX stock moved upwards by 21.48% to $3.28. The company's market cap stands at $86.7 million.
  • Biofrontera BFRI shares moved upwards by 16.72% to $6.42. The company's market cap stands at $92.8 million.
  • Windtree Therapeutics WINT shares rose 11.92% to $1.69. The market value of their outstanding shares is at $47.7 million.
  • Mesoblast MESO stock increased by 8.15% to $4.51. The company's market cap stands at $583.9 million.
  • Evofem Biosciences EVFM shares moved upwards by 7.17% to $0.43. The market value of their outstanding shares is at $70.9 million.
  •  

Losers

  • Pulmatrix PULM stock declined by 15.38% to $0.6 during Wednesday's pre-market session. The market value of their outstanding shares is at $33.7 million.
  • Idera Pharmaceuticals IDRA stock fell 14.95% to $0.74. The market value of their outstanding shares is at $39.0 million.
  • I-MAB IMAB shares decreased by 8.41% to $45.25. The market value of their outstanding shares is at $3.5 billion.
  • Legend Biotech LEGN stock declined by 7.28% to $45.01. The company's market cap stands at $6.5 billion.
  • Applied DNA Sciences APDN shares fell 7.27% to $4.85. The market value of their outstanding shares is at $36.3 million. As per the news, the Q4 earnings report came out 4 days ago.
  • First Wave BioPharma FWBI shares declined by 6.18% to $1.52. The company's market cap stands at $22.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Pre-Market OutlookMarketsMoversBZI-TFMTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...